Therapeutic role of gut microbial metabolite indole propionic acid in a rat model of high-fat diet/Streptozotocin-Induced diabetes: enhancing glucose metabolism, antioxidant defense and PI3K/Akt/GLUT4 signaling pathway
Abstract
BACKGROUND: Type 2 diabetes mellitus (T2DM) is a metabolic disorder characterized by insulin resistance, chronic hyperglycemia, and oxidative stress. Recent research has highlighted the therapeutic potential of gut microbiota-derived metabolites in regulating glucose homeostasis.
AIM: This study evaluated the antidiabetic effects of indole propionic acid (IPA) in a streptozotocin-induced diabetic rat model.
METHOD: Male Wistar rats (n = 30) were divided into Control, T2DM, T2DM + IPA, T2DM+metformin, and IPA-only groups. Following four weeks of oral IPA administration, biochemical, histological, molecular, and metabolomic assessments were performed.
RESULTS: IPA treatment significantly reduced fasting blood glucose levels, improved body weight, and normalized food intake in diabetic rats. Histopathological analysis revealed that IPA preserved pancreatic islet architecture and increased both islet cell counts and diameter. Furthermore, IPA markedly enhanced antioxidant defenses by elevating superoxide dismutase (SOD) and catalase (CAT) activities while reducing malondialdehyde (MDA) content in pancreatic tissue. Molecular analysis showed that IPA upregulated the expression of key insulin signaling genes-PI3K, Akt, and GLUT4-in skeletal muscle and downregulated mTOR expression in pancreatic tissue, indicating improved insulin sensitivity. Molecular docking suggested a potential direct interaction between IPA and GLUT4/PI3K, supporting the gene expression data.
CONCLUSION:…
Read the paper
Related studies
- Metformin as an adjuvant in breast cancer treatment
- Metformin Lysosomal Targeting: A Novel Aspect to Be Investigated for Metformin Repurposing in Neurodegenerative Diseases?
- Aberrant HSF1 signaling activation underlies metformin amelioration of myocardial infarction in mice
- Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines
- Protein Interaction Network for Identifying Vascular Response of Metformin (Oral Antidiabetic)
- Preventing Long COVID With Metformin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.